BioWorld

May 9, 2003

View Archived Issues

Mice Stripped Of Dysferlin Protein Got Muscular Dystrophy, Not Able To Vulcanize Pierced Musculature

Read More

Americans Wary Of Prescription Drugs Coming In From Canada

Read More

Innodia Licenses Diabetes Product From Neurochem, Closes Series A

Read More

Other News To Note

Read More

Guilford Licenses Inhibitor Class To Pfizer As Part Of Broad Deal

Guilford Pharmaceuticals Inc. is licensing an entire class of potential neurodegenerative disease drugs to Pfizer Inc. for $5 million up front in a deal that could become much more lucrative down the road. (BioWorld Today) Read More

PDL's Asthma Therapy Fizzles; Expected After Nuvance Failure

Read More